Phalloidin Synthesis via Solid-Phase Peptide Method
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current synthetic routes for phalloidin and its fluorescent analogs yield insufficient quantities due to low yields and reliance on complex building blocks, making them impractical for high-throughput cell-based screens and treatments for phalloidin-related toxicity.
Innovation Solution
A novel cyclomonomer with actin binding activity, comprising a heptapeptide with a cystyl and tryptophanyl residue linked by a thioether bond, is synthesized using a solid-phase method that includes specific steps for protecting and deprotecting amino acids, forming a thioether bridge, and cyclizing the peptide, resulting in a compound with 50% overall yield and effective fluorescent labeling.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional synthetic routes are used for phalloidin and fluorescent analogs, then the compounds can be produced, but the yields are low (0.5% to 1.3%) and the process complexity increases
Solution Approach 1:
The synthesis process is divided into discrete, manageable steps: (1) solid-phase peptide synthesis of the linear heptapeptide sequence, (2) formation of the thioether bridge between Cys and Trp residues, and (3) cyclization to form the bicyclic phalloidin structure. This segmentation allows each step to be optimized independently and simplifies the overall process compared to conventional multi-step approaches.
Solution Approach 2:
Protecting groups are introduced at strategic positions during peptide synthesis to enable selective reactions later. The thioether bridge formation is performed under controlled conditions before final cyclization, and protecting groups are removed in a planned sequence to reveal reactive sites for bridge formation. This preliminary preparation simplifies subsequent steps and improves overall yield.
2Quantity of substance
If complex building blocks are prepared in solution, then the phalloidin structure can be assembled, but the yields remain insufficient for practical quantities
Solution Approach 1:
The patent replaces solution-phase chemistry with solid-phase peptide synthesis (SPPS). This substitution allows the peptide chain to be assembled on a solid support, enabling automated coupling steps and simplifying purification. The solid phase provides a stable platform for sequential amino acid addition, and the method scales more effectively to produce practical quantities compared to solution methods.
Solution Approach 2:
The synthesis methodology changes key parameters: reaction medium transitions from solution to solid phase, coupling reagents are optimized for each step, and reaction conditions (temperature, time, concentration) are adjusted to maximize yield at each stage. These parameter changes enable the process to achieve both ease of manufacture and practical quantities.
3Reliability
If natural phalloidin is used, then high actin binding activity is achieved, but the cost is high ( ̃$150 per milligram) and supply is limited
Solution Approach 1:
The patent creates synthetic copies of natural phalloidin through SPPS, replicating the bicyclic heptapeptide structure with the same actin binding properties. The synthetic approach allows unlimited production at lower cost, eliminating dependence on natural source cultivation. The synthetic phalloidin maintains the critical thioether bridge and amino acid sequence necessary for high-affinity actin binding.
Solution Approach 2:
The methodology changes from natural product extraction to synthetic chemistry, fundamentally altering how phalloidin is produced. This parameter change enables control over purity, quantity, and cost while maintaining biological activity. The synthetic route allows optimization of each step to ensure the product has the same functional properties as natural phalloidin.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method provides a cost-effective, high-yield synthesis of a fluorescent phalloidin derivative that effectively stains F-actin in fixed cells, enabling high-throughput screens and potential treatments for phalloidin toxicity, with the ability to modulate actin cytoskeletal morphology and cellular processes.
Implementation Method 1
a cyclomonomer having actin binding activity, the cyclomonomer comprising a heptapeptide having a cystyl residue, a prolyl residue, and a tryptophanyl residue and wherein the cystyl residue and the tryptophanyl residue are linked by a thioether bond
Data Source
AI summary
The invention provides a cyclomonomer having actin-binding activity. The cyclomonomer is of utility for the study of the molecular biology of actin polymerization. The cyclomonomer is also useful for the study of and treatment of the toxic effects of Amanita sp. poisoning.